Research and Development Masterclass
The event has been switched to Zoom only due to the weather forecast.
Use our discount code for your ticket! Our discount code 1KEQL1 gives you 20% off. This code is valid through February 8, 2024.
This one-day course features pharma sharing their approach to R&D processes to inform and assist not only attendees own R&D efforts but also the timing and manner of their outreach to investors and pharma. Learn how to plan go-no go decision points that align with investment.
You may participate in-person or virtually.
Topics discussed will include:
Assessment of competition and risk
Importance of a Target Product Profile (TPP)
Role of market assessment
Meaningful milestones in an R&D program
Reducing clinical risk in the preclinical program
GO/NO GO decision points
When external R&D becomes important
Speakers
Agenda
8:45AM Welcome, Introductions of participants
9:00AM-9:30AM Pre-clinical research post COVID (AI, modeling tools, spatial biology)
9:30AM-10:00AM Pharma decision metrics for R spend
10:00AM-10:30AM Meaning milestones in an R&D program
10:30AM-10:45AM Break
10:45AM-11:15AM R&D Milestone exercise
11:15AM-12:00PM R&D investment by stage
12:00PM-1:00PM Lunch
1:00PM-1:30PM Clinical risk management in pre-clinical program
1:30PM-2:00PM Role of GO/NO GO Decision points by R&D stage
2:00PM-2:30PM Exercise mapping participant clinical risk management strategy
2:30PM-2:45PM Break
2:45PM-3:15PM When does external R&D become important
3:15PM-3:45PM How does pharma access external R&D
3:45PM-4:30PM Trends in business development
4:30PM-5:30 PM Virtual Networking Reception